N-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)cyclopropanecarboxamide, 98%, 250mg

2-(2,4-Dichloro-phenoxy)acetonitrile, 97.0%, 25g

4-Amino-2-bromo-6-methylphenol, 98%, 1g

Trichloroacetic Acid (Granulated)>99.0%(T)100g

Square boxes ROTILABO® high form, 2000 ml, 5 Piece(s)

2-(4-Methoxy-phenyl)-3-piperazin-1-ylmethyl-imidazo[1,2-a]pyridine oxalic acid salt, 1g

[1-(2,2,2-trifluoroethyl)-1H-pyrazol-4-yl]methanol, 250mg

N,N'-Bis(dimethylaminomethylene)hydrazine>98.0%(GC)(T)5g

Lafutidine>98.0%(HPLC)(T)250mg

(4-Methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanol, 95.0%, 1g

2H-1-Benzopyran-3,4,5,7-tetrol, 2-(3,4-dihydroxyphenyl)-2-[[2-(3,4-dihydroxyphenyl)-3,4-dihydro-5,7-dihydroxy-2H-1-benzopyran-3-yl]oxy]-3,4-dihydro-, 95%, 1g

4-nitro-1H-1,2,3-benzotriazole, 95%, 250mg

4-(2,4-Dichlorophenoxy)benzaldehyde, 95.0%, 5g